Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | 47,055 | reported | 20 Mar 2026 | tx 12+2,172−2,951 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | SALE | 4D Molecular Therapeutics, Inc. | 310 | 8.61 USD | |
| 20 Mar 2026 | EXERCISE | 4D Molecular Therapeutics, Inc. | 865 | — | |
| 20 Mar 2026 | EXERCISE | 4D Molecular Therapeutics, Inc. | 221 | — | |
| 20 Mar 2026 | SALE | 4D Molecular Therapeutics, Inc. | 80 | 8.61 USD | |
| 20 Mar 2026 | EXERCISE | 4D Molecular Therapeutics, Inc. | 865 | 0.00 USD | deriv |
| 20 Mar 2026 | EXERCISE | 4D Molecular Therapeutics, Inc. | 221 | 0.00 USD | deriv |
| 20 Dec 2025 | SALE | 4D Molecular Therapeutics, Inc. | 310 | 8.68 USD | |
| 20 Dec 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 220 | — | |
| 20 Dec 2025 | SALE | 4D Molecular Therapeutics, Inc. | 79 | 8.68 USD | |
| 20 Dec 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 866 | — | |
| 20 Dec 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 866 | 0.00 USD | deriv |
| 20 Dec 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 220 | 0.00 USD | deriv |